On June 20, 2024, Prairie Capital partnered with founder Dr. Zahra Kashi and senior management to recapitalize Kashi Clinical Laboratories (“Kashi” or the “Company”). Headquartered in Portland, OR, Kashi Clinical Laboratories is a fully accredited clinical laboratory providing specialized solutions to academic institutions, biopharma, hospitals, long-term care facilities and transplant centers around the world. The Company was founded in 2006 to provide high-resolution HLA typing for transplant donor matching. Over time, Kashi expanded its service offering to include post-transplant monitoring, genomic sequencing and other diagnostic testing.
Read the full article: Prairie Capital Announces Partnership with Kashi Clinical Laboratories //
Source: https://www.prairie-capital.com/prairie-capital-announces-partnership-with-kashi-clinical-laboratories/